result solid two-yr average organ sale
growth improv rebound emerg market sale
growth increas visibl yield
greater confid manag invest strategi
yield result
solid ep strong organ sale growth mdlz adj ep
consensu estim mse strong organ
top-line growth profit beat consensu gross profit
miss modestli believ strong organ sale growth
focu increas visibl unchang fy ep guidanc view
result solid organ sale growth average bp
consensu although probabl one-third organ
top-line upsid relat lack neg time expect
around bp recent strategi chang manifest
robust organ sale growth emerg market balanc growth
includ volume/mix price growth exclud
argentina way applaud mondelez break call
unlik coverag balanc corpor growth
volume/mix price gross margin expand bp y-o-i behind
volum leverag product price off-set cost increas off-set
sg invest result flat oper margin y-o-i encourag
strong volum growth emerg market
flattish trend prior quarter global snack categori growth
remain solid similar
total snack organ sale growth
exceed categori growth rate gain share
categori gain hold share market share perform particularli
strong biscuit gain held share categori
chocol gain held share categori
manag expect improv season share
depress due later time higher share
gain held share candi gum portfolio
strong growth global brand includ oreo grew dd
food unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
strength us particularli behind game throne edit china
oreo sale increas dd innov behind local
flavor advertis cadburi sale also increas robust hsd global
indic invest quarter invest
would increas sequenti balanc year reinvest
support growth initi net encourag strong
organ sale growth start year
guidanc average basi high end
organ rang look achiev impli slowdown growth
average balanc year contribut solid guidanc
achiev view
number mdlz adj ep
consensu estim mse strong organ top-line growth drive
profit beat ep upsid driven profit line item
organ revenu growth y-o-i price volume/mix
ahead street account consensu mse organ
sale growth averag basi organ sale growth
acceler vs view
solid rel consensu revenu came essenti in-lin
higher fx headwind offset stronger organ sale growth
lower expect gross margin gm bp consensu bp y-
o-i led gross profit miss slightli lower expect sg led
oper profit beat oper margin bp consensu flat
y-o-i profit line lower expect interest expens
cent benefit vs model lower expect tax rate
cent benefit vs model repurchas share averag
cost quarter y-o-i increas
segment result region basi result driven latin
america post organ sale growth vs consensu
mse aid argentina price msd growth mexico brazil
return growth well asia middl east africa amea
post organ sale growth vs consensu mse
solid result india dd china msd southeast asia msd
europ post organ sale growth consensu
mse solid growth russia dd uk germani north
america vs consensu mse inventori
reduct gum/candi retail total organ sale growth emerg
market vs solid
vol/mix price best quarterli em organ sale result
four year develop market vs
growth free cash flow impact top-line fx
expect ep impact fx vs prior
impli ep guidanc midpoint
estim updat net post ep estim unchang
stronger organ sale growth lower interest expens off-set fx pt
increas reflect price-to-earnings multipl driven improv
organ sale higher staples/cpg multipl continu believ
fundament trend much better us food peer improv
volum overal organ sale growth although larg valuat
premium food peer price-to-earnings ev/ebitda premium keep
us sidelin despit better fundament trend greater perceiv
strateg potenti
price target deriv base case corrobor
higher top-line growth greater margin expans strateg potenti drive
upsid bp volum upsid higher market share trend robust cost
save drive profit upsid market attribut increas strateg
potenti drive valuat ev/ebitda impli ep
growth re-acceler organ sale growth rebound
om bp cost save volum leverag flat
reinvest valuat expand ev/ebitda price-to-earnings
plu hsd strateg premium price-to-earnings all-in histor
yr average ntm price-to-earnings premium food peer given superior
fundament pt support dcf hsd strateg premium
expect market assign
lower price weaker categori volum dissip strateg potenti
price moder vs histor trend due lower inflat emerg
market categori volum growth fulli recov lower price
pressur health well concern dissip strateg potenti
contract valuat contract ev/ebitda impli ep
exhibit bear bull market share price commod cut
rkt hare
growth close market impli
expect although slightli
geographic/categori skew favor
growth vs peer
believ manag increas focu
top-line growth pay drive top-line
acceler lt vs last eight
limit margin expans rel
annual margin expans post
product opportun lower
surfac mind given
ineffici due structur factor
higher mix lower-margin
intern market cost burden
us direct store deliveri believ
bia reinvest behind busi
valuat look fair valuat
price-to-earnings ev/ebitda look
fair larg respect
premium food peer fairli driven
stronger growth prospect vs food peer
compel justifi ow
risk achiev price
lower price weaker price due
lower inflat em volum pressur
higher reinvest dissip
rebound volume/market share
million except ep
good sold
sale
sale bp chang
interest expens net
net incom common
